2.Chronic Gastric Volvulus as a Late Complication of Hepatectomy for Hepatoblastoma in a Child: A Case Report
Han Shin LEE ; Eun Jung JUNG ; Ji Sook PARK ; Taejin PARK
Pediatric Gastroenterology, Hepatology & Nutrition 2019;22(6):608-612
Gastric volvulus (GV) is an uncommon pathology, with 10-20% of cases occurring in children, typically before one year of age. It often occurs in people with congenital diaphragmatic hernias, intestinal malrotation, eventration of the diaphragm, paraesophageal hernias, wandering spleens, asplenism, or intra-abdominal adhesions. We report a rare case of chronic GV after left hemihepatectomy for hepatoblastoma in a child. The patient was a 9-year-old boy who complained of upper abdominal pain and postprandial upper abdominal distension for one year. At the age of 4 months, he was diagnosed with hepatoblastoma and had undergone left hemihepatectomy. The upper gastrointestinal contrast study revealed chronic organoaxial gastric volvulus. After a surgical procedure involving adhesiolysis and an anterior wall gastropexy, the patient improved and the symptoms resolved. Although GV is a rare disease, it should be suspected in a patient with a previous abdominal surgical history who is complaining of abdominal distension and pain.
Abdominal Pain
;
Child
;
Diaphragm
;
Gastropexy
;
Hepatectomy
;
Hepatoblastoma
;
Hernia, Hiatal
;
Hernias, Diaphragmatic, Congenital
;
Humans
;
Male
;
Pathology
;
Rare Diseases
;
Stomach Volvulus
;
Wandering Spleen
3.Anti-bacterial effects of enzymatically-isolated sialic acid from glycomacropeptide in a Helicobacter pylori-infected murine model.
Hye Ji NOH ; Hong Bum KOH ; Hee Kyoung KIM ; Hyang Hyun CHO ; Jeongmin LEE
Nutrition Research and Practice 2017;11(1):11-16
BACKGROUND/OBJECTIVES: Helicobacter pylori (H. pylori) colonization of the stomach mucosa and duodenum is the major cause of acute and chronic gastroduodenal pathology in humans. Efforts to find effective anti-bacterial strategies against H. pylori for the non-antibiotic control of H. pylori infection are urgently required. In this study, we used whey to prepare glycomacropeptide (GMP), from which sialic acid (G-SA) was enzymatically isolated. We investigated the anti-bacterial effects of G-SA against H. pylori in vitro and in an H. pylori-infected murine model. MATERIALS/METHODS: The anti-bacterial activity of G-SA was measured in vitro using the macrodilution method, and interleukin-8 (IL-8) production was measured in H. pylori and AGS cell co-cultures by ELISA. For in vivo study, G-SA 5 g/kg body weight (bw)/day and H. pylori were administered to mice three times over one week. After one week, G-SA 5 g/kg bw/day alone was administered every day for one week. Tumor necrosis factor-α (TNF-α), IL-1β, IL-6, and IL-10 levels were measured by ELISA to determine the anti-inflammatory effects of G-SA. In addition, real-time PCR was performed to measure the genetic expression of cytotoxin-associated gene A (cagA). RESULTS: G-SA inhibited the growth of H. pylori and suppressed IL-8 production in H. pylori and in AGS cell co-cultures in vitro. In the in vivo assay, administration of G-SA reduced levels of IL-1β and IL-6 pro-inflammatory cytokines whereas IL-10 level increased. Also, G-SA suppressed the expression of cagA in the stomach of H. pylori-infected mice. CONCLUSION: G-SA possesses anti-H. pylori activity as well as an anti-H. pylori-induced gastric inflammatory effect in an experimental H. pylori-infected murine model. G-SA has potential as an alternative to antibiotics for the prevention of H. pylori infection and H. pylori-induced gastric disease prevention.
Animals
;
Anti-Bacterial Agents
;
Body Weight
;
Coculture Techniques
;
Colon
;
Cytokines
;
Duodenum
;
Enzyme-Linked Immunosorbent Assay
;
Helicobacter pylori
;
Helicobacter*
;
Humans
;
In Vitro Techniques
;
Interleukin-10
;
Interleukin-6
;
Interleukin-8
;
Methods
;
Mice
;
Mucous Membrane
;
N-Acetylneuraminic Acid*
;
Necrosis
;
Pathology
;
Real-Time Polymerase Chain Reaction
;
Stomach
;
Stomach Diseases
;
Whey
4.Analysis of Gastric and Duodenal Eosinophils in Children with Abdominal Pain Related Functional Gastrointestinal Disorders According to Rome III Criteria.
Eun Hye LEE ; Hye Ran YANG ; Hye Seung LEE
Journal of Neurogastroenterology and Motility 2016;22(3):459-469
BACKGROUND/AIMS: Abdominal pain-related functional gastrointestinal disorder (AP-FGID) is common in children and adults. However, the mechanism of AP-FGID is not clearly known. Recently, micro-inflammation, especially eosinophilia in the gastrointestinal tract, was suggested in the pathophysiology of AP-FGID in adults. The aim of this study was to evaluate the association of gastric and duodenal eosinophilia with pediatric AP-FGID. METHODS: In total, 105 pediatric patients with AP-FGID were recruited and classified into 4 subgroups based on the Rome III criteria. Eosinophil counts in the gastric and duodenal tissues of children with AP-FGID were compared to those from normal pathology references or those of children with Helicobacter pylori infection. Tissue eosinophil counts were also compared among the 4 subtypes of AP-FGID. RESULTS: Eosinophil counts in the gastric antrum and body were significantly higher in children with AP-FGID than normal reference values. Duodenal eosinophil counts were higher in children with AP-FGID, but not significantly when compared with normal reference values. There were no significant differences in eosinophil counts of the stomach or duodenum among the 4 subtypes of AP-FGID. Eosinophils counts in the gastric antrum and body were significantly higher in children with H. pylori infection than in those with AP-FGID. Duodenal eosinophilia was prominent in cases of H. pylori infection, but not statistically significant when compared with AP-FGID. CONCLUSIONS: Our study revealed that gastric eosinophilia is associated with AP-FGID in children, regardless of the subtype of functional abdominal pain. This suggests some contribution of gastrointestinal eosinophils in the development of pediatric AP-FGID.
Abdominal Pain*
;
Adult
;
Child*
;
Duodenum
;
Eosinophilia
;
Eosinophils*
;
Gastrointestinal Diseases*
;
Gastrointestinal Tract
;
Helicobacter pylori
;
Humans
;
Pathology
;
Pyloric Antrum
;
Reference Values
;
Stomach
5.Acute gastritis associated with Epstein-Barr virus infection in a child.
Ji Mok KIM ; Chun Woo SONG ; Kyu Sang SONG ; Jae Young KIM
Korean Journal of Pediatrics 2016;59(Suppl 1):S68-S71
Infectious mononucleosis is Epstein-Barr virus (EBV) inducing a self-limiting clinical syndrome characterized by fever, sore throat, hepatosplenomegaly, and generalized lymphadenopathy. Gastrointestinal symptoms of EBV infection are nonspecific and occur rarely. EBV inducing acute gastrointestinal pathology is poorly recognized without suspicion. Careful consideration is needed to diagnose gastric involvement of EBV infection including gastric lymphoma, gastric cancer, and gastritis. A few recent cases of gastritis associated with EBV infection have been reported in adolescents and adults. However, there is no report of EBV-associated gastritis in early childhood. We experienced a rare case of 4-year-old girl with EBV gastritis confirmed by in situ hybridization.
Adolescent
;
Adult
;
Child*
;
Child, Preschool
;
Epstein-Barr Virus Infections
;
Female
;
Fever
;
Gastritis*
;
Herpesvirus 4, Human*
;
Humans
;
In Situ Hybridization
;
Infectious Mononucleosis
;
Lymphatic Diseases
;
Lymphoma
;
Pathology
;
Pharyngitis
;
Stomach Neoplasms
6.Establishment of animal model with gastric cold syndrome.
Wan-bin YANG ; Bin WEN ; Ling-hang ZHANG ; Hong LIU
China Journal of Chinese Materia Medica 2015;40(20):4031-4036
This study is to establish the gastric cold model of rats. After gastric feeding with cold water for 5 weeks and extra iced water bath in the last 2 weeks, model group show distinct physical sign of gastric cold syndrome. The pathology of gastrics reveals gastricism of model group, while treatment group(treated with Fanzuojin Wan) show mild lesion. Elisa detection of model group show that the solution of interleukin-2 (IL-2) is higher than blank group. The difference with significance among model group, treatment group and blank group reveals the success of the establishment of gastric cold syndrome.
Animals
;
Cold Temperature
;
Disease Models, Animal
;
Female
;
Humans
;
Male
;
Rats
;
Rats, Wistar
;
Stomach
;
chemistry
;
metabolism
;
pathology
;
physiopathology
;
Stomach Diseases
;
metabolism
;
pathology
;
physiopathology
7.A Case of Primary Gastric Amyloidosis with Fulminant Heart Failure.
Seonghun HONG ; Young Woon CHANG ; Jong Kyu BYUN ; Min Je KIM ; Jung Min CHAE ; Sun Hee PARK ; Chi Hyuk OH ; Yong Koo PARK
The Korean Journal of Gastroenterology 2015;66(4):227-230
A 53-year-old woman was admitted with epigastric discomfort and weakness. Laboratory examination at admission showed mild anemia and proteinuria. Esophagogastroduodenoscopy revealed marked mucosal atrophy, diffuse nodularity and granular appearance with mucosal friability. Biopsy was performed on the antrum and body of the stomach. On the next day, the patient began to complain of severe dyspnea, and hypoxia was present on pulse oximetry. Therefore, emergency echocardiography was conducted and it showed restrictive cardiomyopathy along with thrombus in the left atrium. With time, heart failure was aggravated despite intensive management. The result of gastric biopsy revealed amyloid deposits which stained positively with Congo red. On immunohistochemistry study, kappa and lambda chain were present. In addition, kappa chain was significantly elevated in urine and serum on electrophoresis. Although the patient was finally diagnosed as having primary gastric amyloidosis with restrictive cardiomyopathy, her general condition rapidly deteriorated and died at 12th hospital day. When obscure gastric lesion is encountered, performing gastric biopsy is strongly recommended since it be primary gastric amyloidosis. Herein, we present an unusual case of primary gastric amyloidosis.
Amyloidosis/complications/*diagnosis/pathology
;
Endoscopy, Digestive System
;
Female
;
Heart Atria/diagnostic imaging
;
Heart Failure/complications/*diagnosis
;
Humans
;
Immunoglobulin kappa-Chains/blood/urine
;
Immunoglobulin lambda-Chains/blood/urine
;
Immunohistochemistry
;
Magnetic Resonance Imaging
;
Middle Aged
;
Stomach Diseases/complications/*diagnosis/pathology
;
Thrombosis/diagnosis/diagnostic imaging
;
Tomography, X-Ray Computed
;
Ultrasonography
8.Changes in Upper Gastrointestinal Diseases according to Improvement of Helicobacter pylori Prevalence Rate in Korea.
The Korean Journal of Gastroenterology 2015;65(4):199-204
Helicobacter pylori can cause variety of upper gastrointestinal disorders such as peptic ulcer, mucosa associated lymphoid tissue (MALT)-lymphoma, and gastric cancer. The prevalence of H. pylori infection has significantly decreased in Korea since 1998 owing to active eradication of H. pylori. Along with its decrease, the prevalence of peptic ulcer has also decreased. However, the mean age of gastric ulcer increased and this is considered to be due to increase in NSAID prescription. Gastric cancer is one of the leading causes of cancer deaths in Korea and Japan, and IARC/WHO has classified H. pylori as class one carcinogen of gastric cancer. Despite the decreasing prevalence of H. pylori infection, the total number of gastric cancer in Korea has continuously increased from 2006 to 2011. Nevertheless, the 5 year survival rate of gastric cancer patients significantly increased from 42.8% in 1993 to 67% in 2010. This increase in survival rate seems to be mainly due to early detection of gastric cancer and endoscopic mucosal dissection treatment. Based on these findings, the prevalence of peptic ulcer is expected to decrease even more with H. pylori eradication therapy and NSAID will become the main cause of peptic ulcer. Although the prevalence of gastric cancer has not changed along with decreased the prevalence of H. pylori, gastric cancer is expected to decrease in the long run with the help of eradication therapy and endoscopic treatment of precancerous lesions.
Anti-Bacterial Agents/therapeutic use
;
Anti-Inflammatory Agents, Non-Steroidal/adverse effects
;
Gastrointestinal Diseases/complications/*epidemiology
;
Helicobacter Infections/complications/drug therapy/epidemiology
;
Humans
;
Lymphoma, B-Cell, Marginal Zone/epidemiology
;
Peptic Ulcer/epidemiology/etiology
;
Prevalence
;
Stomach Neoplasms/etiology/mortality/pathology
9.Establishment of animal model with gastric hot syndrome.
Wan-bin YANG ; Bin WEN ; Ling-hang ZHANG ; Hong LIU
China Journal of Chinese Materia Medica 2015;40(18):3644-3649
This study is to establish the gastric hot model of rats. After gastric feeding with ethanol solution for 3 weeks and feeding with extra capsaicin and ethanol solution for another 2 weeks, model group show distinct physical sign of gastric hot syndrome. The pathology of gastrics reveals gastricism of model group, while treatment group (treat with Zuojin Wan) shows mild lesion. Elisa detection of model group show that the solution of interleukin-2 (IL-2) is higher than the blank group. The obvious difference among model group, treatment group and blank group reveals the success of the establishment of gastric hot model.
Animals
;
Disease Models, Animal
;
Drugs, Chinese Herbal
;
administration & dosage
;
Eating
;
Female
;
Humans
;
Male
;
Rats
;
Rats, Wistar
;
Stomach Diseases
;
drug therapy
;
pathology
;
physiopathology
10.Changes in serum pepsinogen in patients with liver cirrhosis and portal hypertensive gastropathy.
Journal of Southern Medical University 2014;34(1):141-143
OBJECTIVETo determine serum pepsinogen levels in patients with liver cirrhosis and investigate the functions of the gastric mucosa in these patients with concurrent portal hypertensive gastropathy (PHG).
METHODSFifty-one patients with liver cirrhosis and 22 healthy controls were studied by gastroscopy. The hepatic function of the patients with or without PHG were evaluated with Child-Pugh grade. Helicobacter pylori infection was detected using rapid urease test or exhalation of carbon 13. The serum pepsinogen I and II levels were tested by latex-enhanced immunoturbidimetry to calculate the PGI/PGII ratio (PGR).
RESULTSIn cirrhotic patients, the levels of serum PGI and PGR were lower than those in the healthy controls. The patients without PHG had a serum PGI level of 49.48+23.86 µg/L, significantly lower than that in PHG patients (74.85+30.27 µg/L, P=0.000). The levels of serum PG II in patients with H.pylori infection was significantly higher that in patients free of H.pylori infection (P=0.003).
CONCLUSIONThe serum level of PGI decreases obviously in patients with hepatic cirrhosis and PHG, who can have damages of the gastric mucosa lamina propria and reduced secretory function of the gastric mucosa. H.pylori infection may affect the level of PGII. There is no significant correlation between serum PG level and liver function, but to a certain extent, serum PG level especially PGI can reflect the function of gastric mucosa in patients of liver cirrhosis.
Adult ; Case-Control Studies ; Female ; Gastric Mucosa ; pathology ; Helicobacter Infections ; Humans ; Hypertension, Portal ; complications ; Liver Cirrhosis ; complications ; Male ; Middle Aged ; Pepsinogen A ; blood ; Stomach Diseases ; blood ; etiology ; microbiology

Result Analysis
Print
Save
E-mail